SBS 15th Annual Conference & Exhibition Lille, France April 26-30, 2009 Podium Presentation Abstracts Titles In Alphabetical Order Beginning with: O - R On Non-cancer Kinase Inhibitor Discovery & Development at GSK Gary Smith, GSK, USA Opioid Receptor Trafficking in vivoand Behavior Bridget Kieffer, IGBMC, France Peptides Tailored to Interfere with Protein Interaction and Function Katya Arndt, University of Freiburg, Germany Picoliter Dispense for Direct Titration Kenneth Ward, Hewlett-Packard, USA Pooled Lentivirus-based RNAi Screens to Determine Cancer Genetic Susceptibilities Robert Rottapel, Ontario Cancer Institute, Canada Primary Human Cell Systems Analysis of Drug Mechanisms Ellen Berg, BioSeek, Inc., USA Protein Kinases of the Innate Immune System as Drug Targets Sir Philip Cohen, University of Dundee, UK Progress in Elucidating Allostery and Functional Selectivity of G-protein Coupled Receptors by Feeding New Structural and Binformation into Molecular Modelling and Fast Molecular Dynamics Approaches Marta Filizola, Mount Sinai School of Medicine, USA Receptor Allosterism & Functional Selectivity: Better Drugs or Just Interesting Pharmacology? Terry Kenakin, GlaxoSmithKline, USA Repositioning by Highly Efficient In-Vivo Mouse Phenotypic Screening: Discovery of MLR-1023 Christopher Lipinski, Melior Discovery, USA Reversibility of Amantadine Inhibition in the M2 Proton Channel of Influenza A Virus Victoria Balannik, Northwestern University, USA Role of Nuclear Receptors in Atopic Diseases (Dermatitis and Asthma) Pierre Chambon, Collège-de-France, France Go Back to the Start Page List talks by Track List talks by Day and Session List talks by Presenting Author List talks in Alphabetical Order